nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—CYP3A4—Thiotepa—sarcoma	0.125	0.169	CbGbCtD
Loratadine—ABCB1—Dactinomycin—sarcoma	0.0998	0.136	CbGbCtD
Loratadine—ABCB1—Mitoxantrone—sarcoma	0.0894	0.121	CbGbCtD
Loratadine—CYP2C8—Etoposide—sarcoma	0.0832	0.113	CbGbCtD
Loratadine—ABCB1—Vincristine—sarcoma	0.0615	0.0835	CbGbCtD
Loratadine—ABCB1—Etoposide—sarcoma	0.0563	0.0765	CbGbCtD
Loratadine—CYP3A4—Mitoxantrone—sarcoma	0.0535	0.0727	CbGbCtD
Loratadine—ABCB1—Doxorubicin—sarcoma	0.0384	0.0522	CbGbCtD
Loratadine—CYP3A4—Vincristine—sarcoma	0.0368	0.05	CbGbCtD
Loratadine—CYP2D6—Doxorubicin—sarcoma	0.0362	0.0492	CbGbCtD
Loratadine—CYP3A4—Etoposide—sarcoma	0.0338	0.0458	CbGbCtD
Loratadine—CYP3A4—Doxorubicin—sarcoma	0.023	0.0313	CbGbCtD
Loratadine—Alopecia—Vincristine—sarcoma	0.0013	0.00492	CcSEcCtD
Loratadine—Malaise—Dactinomycin—sarcoma	0.00129	0.00489	CcSEcCtD
Loratadine—Salivary hypersecretion—Epirubicin—sarcoma	0.00129	0.00489	CcSEcCtD
Loratadine—Arrhythmia—Mitoxantrone—sarcoma	0.00128	0.00485	CcSEcCtD
Loratadine—Alopecia—Mitoxantrone—sarcoma	0.00126	0.00479	CcSEcCtD
Loratadine—Cough—Thiotepa—sarcoma	0.00126	0.00477	CcSEcCtD
Loratadine—Hepatobiliary disease—Etoposide—sarcoma	0.00125	0.00475	CcSEcCtD
Loratadine—Hypertension—Thiotepa—sarcoma	0.00124	0.00472	CcSEcCtD
Loratadine—Myalgia—Thiotepa—sarcoma	0.00123	0.00465	CcSEcCtD
Loratadine—Dysgeusia—Mitoxantrone—sarcoma	0.00122	0.00462	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00122	0.00462	CcSEcCtD
Loratadine—Myalgia—Dactinomycin—sarcoma	0.00122	0.00462	CcSEcCtD
Loratadine—Discomfort—Dactinomycin—sarcoma	0.0012	0.00456	CcSEcCtD
Loratadine—Salivary hypersecretion—Doxorubicin—sarcoma	0.00119	0.00453	CcSEcCtD
Loratadine—Agitation—Vincristine—sarcoma	0.00117	0.00446	CcSEcCtD
Loratadine—Ill-defined disorder—Mitoxantrone—sarcoma	0.00115	0.00438	CcSEcCtD
Loratadine—Nervous system disorder—Thiotepa—sarcoma	0.00115	0.00438	CcSEcCtD
Loratadine—Tachycardia—Thiotepa—sarcoma	0.00115	0.00435	CcSEcCtD
Loratadine—Skin disorder—Thiotepa—sarcoma	0.00114	0.00433	CcSEcCtD
Loratadine—Malaise—Mitoxantrone—sarcoma	0.00112	0.00426	CcSEcCtD
Loratadine—Hypertension—Vincristine—sarcoma	0.0011	0.00419	CcSEcCtD
Loratadine—Myalgia—Vincristine—sarcoma	0.00109	0.00413	CcSEcCtD
Loratadine—Cough—Mitoxantrone—sarcoma	0.00109	0.00412	CcSEcCtD
Loratadine—Hypertension—Mitoxantrone—sarcoma	0.00107	0.00408	CcSEcCtD
Loratadine—Immune system disorder—Etoposide—sarcoma	0.00107	0.00408	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00107	0.00407	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00106	0.00403	CcSEcCtD
Loratadine—Chest pain—Mitoxantrone—sarcoma	0.00106	0.00402	CcSEcCtD
Loratadine—Myalgia—Mitoxantrone—sarcoma	0.00106	0.00402	CcSEcCtD
Loratadine—Paraesthesia—Thiotepa—sarcoma	0.00106	0.00401	CcSEcCtD
Loratadine—Alopecia—Etoposide—sarcoma	0.00105	0.00399	CcSEcCtD
Loratadine—Discomfort—Mitoxantrone—sarcoma	0.00105	0.00397	CcSEcCtD
Loratadine—Somnolence—Thiotepa—sarcoma	0.00105	0.00397	CcSEcCtD
Loratadine—Anaphylactic shock—Vincristine—sarcoma	0.00104	0.00396	CcSEcCtD
Loratadine—Dyspepsia—Thiotepa—sarcoma	0.00104	0.00393	CcSEcCtD
Loratadine—Increased appetite—Epirubicin—sarcoma	0.00103	0.00389	CcSEcCtD
Loratadine—Nervous system disorder—Vincristine—sarcoma	0.00102	0.00388	CcSEcCtD
Loratadine—Anaphylactic shock—Mitoxantrone—sarcoma	0.00102	0.00385	CcSEcCtD
Loratadine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00102	0.00385	CcSEcCtD
Loratadine—Fatigue—Thiotepa—sarcoma	0.00101	0.00385	CcSEcCtD
Loratadine—Dysgeusia—Etoposide—sarcoma	0.00101	0.00385	CcSEcCtD
Loratadine—Dermatitis bullous—Epirubicin—sarcoma	0.00101	0.00382	CcSEcCtD
Loratadine—Fatigue—Dactinomycin—sarcoma	0.00101	0.00382	CcSEcCtD
Loratadine—Pain—Thiotepa—sarcoma	0.00101	0.00382	CcSEcCtD
Loratadine—Constipation—Thiotepa—sarcoma	0.00101	0.00382	CcSEcCtD
Loratadine—Shock—Mitoxantrone—sarcoma	0.000999	0.00379	CcSEcCtD
Loratadine—Pain—Dactinomycin—sarcoma	0.000998	0.00379	CcSEcCtD
Loratadine—Tachycardia—Mitoxantrone—sarcoma	0.000991	0.00376	CcSEcCtD
Loratadine—Skin disorder—Mitoxantrone—sarcoma	0.000986	0.00374	CcSEcCtD
Loratadine—Lethargy—Epirubicin—sarcoma	0.000983	0.00373	CcSEcCtD
Loratadine—Hypotension—Vincristine—sarcoma	0.000974	0.0037	CcSEcCtD
Loratadine—Feeling abnormal—Thiotepa—sarcoma	0.000969	0.00368	CcSEcCtD
Loratadine—Feeling abnormal—Dactinomycin—sarcoma	0.000962	0.00365	CcSEcCtD
Loratadine—Gastrointestinal pain—Thiotepa—sarcoma	0.000961	0.00365	CcSEcCtD
Loratadine—Ill-defined disorder—Etoposide—sarcoma	0.00096	0.00364	CcSEcCtD
Loratadine—Gastrointestinal pain—Dactinomycin—sarcoma	0.000954	0.00362	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Vincristine—sarcoma	0.00095	0.0036	CcSEcCtD
Loratadine—Hypotension—Mitoxantrone—sarcoma	0.000949	0.0036	CcSEcCtD
Loratadine—Increased appetite—Doxorubicin—sarcoma	0.000949	0.0036	CcSEcCtD
Loratadine—Insomnia—Vincristine—sarcoma	0.000943	0.00358	CcSEcCtD
Loratadine—Paraesthesia—Vincristine—sarcoma	0.000936	0.00355	CcSEcCtD
Loratadine—Malaise—Etoposide—sarcoma	0.000933	0.00354	CcSEcCtD
Loratadine—Dermatitis bullous—Doxorubicin—sarcoma	0.000933	0.00354	CcSEcCtD
Loratadine—Abdominal pain—Thiotepa—sarcoma	0.00093	0.00353	CcSEcCtD
Loratadine—Body temperature increased—Thiotepa—sarcoma	0.00093	0.00353	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000925	0.00351	CcSEcCtD
Loratadine—Body temperature increased—Dactinomycin—sarcoma	0.000923	0.0035	CcSEcCtD
Loratadine—Abdominal pain—Dactinomycin—sarcoma	0.000923	0.0035	CcSEcCtD
Loratadine—Paraesthesia—Mitoxantrone—sarcoma	0.000912	0.00346	CcSEcCtD
Loratadine—Loss of consciousness—Etoposide—sarcoma	0.00091	0.00345	CcSEcCtD
Loratadine—Lethargy—Doxorubicin—sarcoma	0.00091	0.00345	CcSEcCtD
Loratadine—Cough—Etoposide—sarcoma	0.000903	0.00343	CcSEcCtD
Loratadine—Somnolence—Mitoxantrone—sarcoma	0.000903	0.00343	CcSEcCtD
Loratadine—Gastrointestinal disorder—Vincristine—sarcoma	0.0009	0.00342	CcSEcCtD
Loratadine—Fatigue—Vincristine—sarcoma	0.000899	0.00341	CcSEcCtD
Loratadine—Dyspepsia—Mitoxantrone—sarcoma	0.000894	0.00339	CcSEcCtD
Loratadine—Hypertension—Etoposide—sarcoma	0.000893	0.00339	CcSEcCtD
Loratadine—Pain—Vincristine—sarcoma	0.000892	0.00338	CcSEcCtD
Loratadine—Constipation—Vincristine—sarcoma	0.000892	0.00338	CcSEcCtD
Loratadine—Chest pain—Etoposide—sarcoma	0.000881	0.00334	CcSEcCtD
Loratadine—Abdominal pain upper—Epirubicin—sarcoma	0.00088	0.00334	CcSEcCtD
Loratadine—Fatigue—Mitoxantrone—sarcoma	0.000875	0.00332	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000875	0.00332	CcSEcCtD
Loratadine—Discomfort—Etoposide—sarcoma	0.00087	0.0033	CcSEcCtD
Loratadine—Constipation—Mitoxantrone—sarcoma	0.000868	0.0033	CcSEcCtD
Loratadine—Pain—Mitoxantrone—sarcoma	0.000868	0.0033	CcSEcCtD
Loratadine—Gastrointestinal pain—Vincristine—sarcoma	0.000853	0.00324	CcSEcCtD
Loratadine—Gastritis—Epirubicin—sarcoma	0.000853	0.00324	CcSEcCtD
Loratadine—Anaphylactic shock—Etoposide—sarcoma	0.000845	0.00321	CcSEcCtD
Loratadine—Asthenia—Thiotepa—sarcoma	0.000844	0.0032	CcSEcCtD
Loratadine—Asthenia—Dactinomycin—sarcoma	0.000837	0.00318	CcSEcCtD
Loratadine—Feeling abnormal—Mitoxantrone—sarcoma	0.000837	0.00318	CcSEcCtD
Loratadine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00083	0.00315	CcSEcCtD
Loratadine—Tachycardia—Etoposide—sarcoma	0.000824	0.00313	CcSEcCtD
Loratadine—Abdominal pain—Vincristine—sarcoma	0.000824	0.00313	CcSEcCtD
Loratadine—Body temperature increased—Vincristine—sarcoma	0.000824	0.00313	CcSEcCtD
Loratadine—Skin disorder—Etoposide—sarcoma	0.00082	0.00311	CcSEcCtD
Loratadine—Abdominal pain upper—Doxorubicin—sarcoma	0.000814	0.00309	CcSEcCtD
Loratadine—Diarrhoea—Thiotepa—sarcoma	0.000805	0.00305	CcSEcCtD
Loratadine—Body temperature increased—Mitoxantrone—sarcoma	0.000803	0.00305	CcSEcCtD
Loratadine—Abdominal pain—Mitoxantrone—sarcoma	0.000803	0.00305	CcSEcCtD
Loratadine—Diarrhoea—Dactinomycin—sarcoma	0.000798	0.00303	CcSEcCtD
Loratadine—Hypotension—Etoposide—sarcoma	0.000789	0.003	CcSEcCtD
Loratadine—Gastritis—Doxorubicin—sarcoma	0.000789	0.00299	CcSEcCtD
Loratadine—Dizziness—Thiotepa—sarcoma	0.000778	0.00295	CcSEcCtD
Loratadine—Pollakiuria—Epirubicin—sarcoma	0.000769	0.00292	CcSEcCtD
Loratadine—Paraesthesia—Etoposide—sarcoma	0.000758	0.00288	CcSEcCtD
Loratadine—Somnolence—Etoposide—sarcoma	0.000751	0.00285	CcSEcCtD
Loratadine—Asthenia—Vincristine—sarcoma	0.000748	0.00284	CcSEcCtD
Loratadine—Vomiting—Thiotepa—sarcoma	0.000748	0.00284	CcSEcCtD
Loratadine—Drowsiness—Epirubicin—sarcoma	0.000742	0.00282	CcSEcCtD
Loratadine—Vomiting—Dactinomycin—sarcoma	0.000742	0.00282	CcSEcCtD
Loratadine—Rash—Thiotepa—sarcoma	0.000741	0.00281	CcSEcCtD
Loratadine—Dermatitis—Thiotepa—sarcoma	0.000741	0.00281	CcSEcCtD
Loratadine—Headache—Thiotepa—sarcoma	0.000737	0.0028	CcSEcCtD
Loratadine—Rash—Dactinomycin—sarcoma	0.000736	0.00279	CcSEcCtD
Loratadine—Gastrointestinal disorder—Etoposide—sarcoma	0.000729	0.00277	CcSEcCtD
Loratadine—Asthenia—Mitoxantrone—sarcoma	0.000729	0.00276	CcSEcCtD
Loratadine—Fatigue—Etoposide—sarcoma	0.000728	0.00276	CcSEcCtD
Loratadine—Pain—Etoposide—sarcoma	0.000722	0.00274	CcSEcCtD
Loratadine—Constipation—Etoposide—sarcoma	0.000722	0.00274	CcSEcCtD
Loratadine—Diarrhoea—Vincristine—sarcoma	0.000713	0.00271	CcSEcCtD
Loratadine—Pollakiuria—Doxorubicin—sarcoma	0.000712	0.0027	CcSEcCtD
Loratadine—Hepatobiliary disease—Epirubicin—sarcoma	0.000702	0.00266	CcSEcCtD
Loratadine—Epistaxis—Epirubicin—sarcoma	0.0007	0.00266	CcSEcCtD
Loratadine—Nausea—Thiotepa—sarcoma	0.000698	0.00265	CcSEcCtD
Loratadine—Feeling abnormal—Etoposide—sarcoma	0.000696	0.00264	CcSEcCtD
Loratadine—Diarrhoea—Mitoxantrone—sarcoma	0.000695	0.00264	CcSEcCtD
Loratadine—Nausea—Dactinomycin—sarcoma	0.000693	0.00263	CcSEcCtD
Loratadine—Gastrointestinal pain—Etoposide—sarcoma	0.000691	0.00262	CcSEcCtD
Loratadine—Dizziness—Vincristine—sarcoma	0.000689	0.00262	CcSEcCtD
Loratadine—Drowsiness—Doxorubicin—sarcoma	0.000687	0.00261	CcSEcCtD
Loratadine—Body temperature increased—Etoposide—sarcoma	0.000668	0.00253	CcSEcCtD
Loratadine—Abdominal pain—Etoposide—sarcoma	0.000668	0.00253	CcSEcCtD
Loratadine—Vomiting—Vincristine—sarcoma	0.000663	0.00252	CcSEcCtD
Loratadine—Pharyngitis—Epirubicin—sarcoma	0.000661	0.00251	CcSEcCtD
Loratadine—Rash—Vincristine—sarcoma	0.000657	0.00249	CcSEcCtD
Loratadine—Dermatitis—Vincristine—sarcoma	0.000657	0.00249	CcSEcCtD
Loratadine—Headache—Vincristine—sarcoma	0.000653	0.00248	CcSEcCtD
Loratadine—Hepatobiliary disease—Doxorubicin—sarcoma	0.00065	0.00247	CcSEcCtD
Loratadine—Epistaxis—Doxorubicin—sarcoma	0.000648	0.00246	CcSEcCtD
Loratadine—Vomiting—Mitoxantrone—sarcoma	0.000646	0.00245	CcSEcCtD
Loratadine—Rash—Mitoxantrone—sarcoma	0.00064	0.00243	CcSEcCtD
Loratadine—Dermatitis—Mitoxantrone—sarcoma	0.00064	0.00243	CcSEcCtD
Loratadine—Headache—Mitoxantrone—sarcoma	0.000636	0.00241	CcSEcCtD
Loratadine—Tinnitus—Epirubicin—sarcoma	0.000621	0.00236	CcSEcCtD
Loratadine—Nausea—Vincristine—sarcoma	0.000619	0.00235	CcSEcCtD
Loratadine—Pharyngitis—Doxorubicin—sarcoma	0.000612	0.00232	CcSEcCtD
Loratadine—Asthenia—Etoposide—sarcoma	0.000606	0.0023	CcSEcCtD
Loratadine—Nausea—Mitoxantrone—sarcoma	0.000603	0.00229	CcSEcCtD
Loratadine—Immune system disorder—Epirubicin—sarcoma	0.000602	0.00228	CcSEcCtD
Loratadine—Arrhythmia—Epirubicin—sarcoma	0.000595	0.00226	CcSEcCtD
Loratadine—Alopecia—Epirubicin—sarcoma	0.000589	0.00223	CcSEcCtD
Loratadine—Diarrhoea—Etoposide—sarcoma	0.000578	0.00219	CcSEcCtD
Loratadine—Tinnitus—Doxorubicin—sarcoma	0.000575	0.00218	CcSEcCtD
Loratadine—Tension—Epirubicin—sarcoma	0.000569	0.00216	CcSEcCtD
Loratadine—Dysgeusia—Epirubicin—sarcoma	0.000568	0.00216	CcSEcCtD
Loratadine—Nervousness—Epirubicin—sarcoma	0.000563	0.00214	CcSEcCtD
Loratadine—Dizziness—Etoposide—sarcoma	0.000559	0.00212	CcSEcCtD
Loratadine—Immune system disorder—Doxorubicin—sarcoma	0.000557	0.00211	CcSEcCtD
Loratadine—Arrhythmia—Doxorubicin—sarcoma	0.000551	0.00209	CcSEcCtD
Loratadine—Alopecia—Doxorubicin—sarcoma	0.000545	0.00207	CcSEcCtD
Loratadine—Ill-defined disorder—Epirubicin—sarcoma	0.000538	0.00204	CcSEcCtD
Loratadine—Vomiting—Etoposide—sarcoma	0.000537	0.00204	CcSEcCtD
Loratadine—Agitation—Epirubicin—sarcoma	0.000533	0.00202	CcSEcCtD
Loratadine—Rash—Etoposide—sarcoma	0.000533	0.00202	CcSEcCtD
Loratadine—Dermatitis—Etoposide—sarcoma	0.000532	0.00202	CcSEcCtD
Loratadine—Headache—Etoposide—sarcoma	0.000529	0.00201	CcSEcCtD
Loratadine—Tension—Doxorubicin—sarcoma	0.000527	0.002	CcSEcCtD
Loratadine—Dysgeusia—Doxorubicin—sarcoma	0.000526	0.00199	CcSEcCtD
Loratadine—Malaise—Epirubicin—sarcoma	0.000523	0.00199	CcSEcCtD
Loratadine—Nervousness—Doxorubicin—sarcoma	0.000521	0.00198	CcSEcCtD
Loratadine—Syncope—Epirubicin—sarcoma	0.00052	0.00197	CcSEcCtD
Loratadine—Palpitations—Epirubicin—sarcoma	0.000513	0.00195	CcSEcCtD
Loratadine—Loss of consciousness—Epirubicin—sarcoma	0.00051	0.00193	CcSEcCtD
Loratadine—Cough—Epirubicin—sarcoma	0.000506	0.00192	CcSEcCtD
Loratadine—Nausea—Etoposide—sarcoma	0.000502	0.0019	CcSEcCtD
Loratadine—Hypertension—Epirubicin—sarcoma	0.000501	0.0019	CcSEcCtD
Loratadine—Ill-defined disorder—Doxorubicin—sarcoma	0.000498	0.00189	CcSEcCtD
Loratadine—Myalgia—Epirubicin—sarcoma	0.000494	0.00187	CcSEcCtD
Loratadine—Chest pain—Epirubicin—sarcoma	0.000494	0.00187	CcSEcCtD
Loratadine—Agitation—Doxorubicin—sarcoma	0.000493	0.00187	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00049	0.00186	CcSEcCtD
Loratadine—Discomfort—Epirubicin—sarcoma	0.000488	0.00185	CcSEcCtD
Loratadine—Malaise—Doxorubicin—sarcoma	0.000484	0.00184	CcSEcCtD
Loratadine—Dry mouth—Epirubicin—sarcoma	0.000483	0.00183	CcSEcCtD
Loratadine—Syncope—Doxorubicin—sarcoma	0.000481	0.00183	CcSEcCtD
Loratadine—Palpitations—Doxorubicin—sarcoma	0.000474	0.0018	CcSEcCtD
Loratadine—Anaphylactic shock—Epirubicin—sarcoma	0.000473	0.0018	CcSEcCtD
Loratadine—Loss of consciousness—Doxorubicin—sarcoma	0.000472	0.00179	CcSEcCtD
Loratadine—Cough—Doxorubicin—sarcoma	0.000468	0.00178	CcSEcCtD
Loratadine—Shock—Epirubicin—sarcoma	0.000466	0.00177	CcSEcCtD
Loratadine—Nervous system disorder—Epirubicin—sarcoma	0.000464	0.00176	CcSEcCtD
Loratadine—Hypertension—Doxorubicin—sarcoma	0.000463	0.00176	CcSEcCtD
Loratadine—Tachycardia—Epirubicin—sarcoma	0.000462	0.00175	CcSEcCtD
Loratadine—Skin disorder—Epirubicin—sarcoma	0.00046	0.00175	CcSEcCtD
Loratadine—Chest pain—Doxorubicin—sarcoma	0.000457	0.00173	CcSEcCtD
Loratadine—Myalgia—Doxorubicin—sarcoma	0.000457	0.00173	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000454	0.00172	CcSEcCtD
Loratadine—Discomfort—Doxorubicin—sarcoma	0.000451	0.00171	CcSEcCtD
Loratadine—Dry mouth—Doxorubicin—sarcoma	0.000447	0.0017	CcSEcCtD
Loratadine—Hypotension—Epirubicin—sarcoma	0.000442	0.00168	CcSEcCtD
Loratadine—Anaphylactic shock—Doxorubicin—sarcoma	0.000438	0.00166	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000431	0.00164	CcSEcCtD
Loratadine—Shock—Doxorubicin—sarcoma	0.000431	0.00164	CcSEcCtD
Loratadine—Nervous system disorder—Doxorubicin—sarcoma	0.00043	0.00163	CcSEcCtD
Loratadine—Insomnia—Epirubicin—sarcoma	0.000428	0.00163	CcSEcCtD
Loratadine—Tachycardia—Doxorubicin—sarcoma	0.000428	0.00162	CcSEcCtD
Loratadine—Skin disorder—Doxorubicin—sarcoma	0.000426	0.00161	CcSEcCtD
Loratadine—Paraesthesia—Epirubicin—sarcoma	0.000425	0.00161	CcSEcCtD
Loratadine—Somnolence—Epirubicin—sarcoma	0.000421	0.0016	CcSEcCtD
Loratadine—Dyspepsia—Epirubicin—sarcoma	0.000417	0.00158	CcSEcCtD
Loratadine—Hypotension—Doxorubicin—sarcoma	0.000409	0.00155	CcSEcCtD
Loratadine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000409	0.00155	CcSEcCtD
Loratadine—Fatigue—Epirubicin—sarcoma	0.000408	0.00155	CcSEcCtD
Loratadine—Constipation—Epirubicin—sarcoma	0.000405	0.00154	CcSEcCtD
Loratadine—Pain—Epirubicin—sarcoma	0.000405	0.00154	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000399	0.00151	CcSEcCtD
Loratadine—Insomnia—Doxorubicin—sarcoma	0.000396	0.0015	CcSEcCtD
Loratadine—Paraesthesia—Doxorubicin—sarcoma	0.000393	0.00149	CcSEcCtD
Loratadine—Feeling abnormal—Epirubicin—sarcoma	0.00039	0.00148	CcSEcCtD
Loratadine—Somnolence—Doxorubicin—sarcoma	0.000389	0.00148	CcSEcCtD
Loratadine—Gastrointestinal pain—Epirubicin—sarcoma	0.000387	0.00147	CcSEcCtD
Loratadine—Dyspepsia—Doxorubicin—sarcoma	0.000386	0.00146	CcSEcCtD
Loratadine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000378	0.00144	CcSEcCtD
Loratadine—Fatigue—Doxorubicin—sarcoma	0.000378	0.00143	CcSEcCtD
Loratadine—Pain—Doxorubicin—sarcoma	0.000375	0.00142	CcSEcCtD
Loratadine—Constipation—Doxorubicin—sarcoma	0.000375	0.00142	CcSEcCtD
Loratadine—Body temperature increased—Epirubicin—sarcoma	0.000374	0.00142	CcSEcCtD
Loratadine—Abdominal pain—Epirubicin—sarcoma	0.000374	0.00142	CcSEcCtD
Loratadine—Feeling abnormal—Doxorubicin—sarcoma	0.000361	0.00137	CcSEcCtD
Loratadine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000358	0.00136	CcSEcCtD
Loratadine—Abdominal pain—Doxorubicin—sarcoma	0.000346	0.00131	CcSEcCtD
Loratadine—Body temperature increased—Doxorubicin—sarcoma	0.000346	0.00131	CcSEcCtD
Loratadine—Asthenia—Epirubicin—sarcoma	0.00034	0.00129	CcSEcCtD
Loratadine—Diarrhoea—Epirubicin—sarcoma	0.000324	0.00123	CcSEcCtD
Loratadine—Asthenia—Doxorubicin—sarcoma	0.000314	0.00119	CcSEcCtD
Loratadine—Dizziness—Epirubicin—sarcoma	0.000313	0.00119	CcSEcCtD
Loratadine—Vomiting—Epirubicin—sarcoma	0.000301	0.00114	CcSEcCtD
Loratadine—Diarrhoea—Doxorubicin—sarcoma	0.0003	0.00114	CcSEcCtD
Loratadine—Rash—Epirubicin—sarcoma	0.000299	0.00113	CcSEcCtD
Loratadine—Dermatitis—Epirubicin—sarcoma	0.000298	0.00113	CcSEcCtD
Loratadine—Headache—Epirubicin—sarcoma	0.000297	0.00113	CcSEcCtD
Loratadine—Dizziness—Doxorubicin—sarcoma	0.00029	0.0011	CcSEcCtD
Loratadine—Nausea—Epirubicin—sarcoma	0.000281	0.00107	CcSEcCtD
Loratadine—Vomiting—Doxorubicin—sarcoma	0.000279	0.00106	CcSEcCtD
Loratadine—Rash—Doxorubicin—sarcoma	0.000276	0.00105	CcSEcCtD
Loratadine—Dermatitis—Doxorubicin—sarcoma	0.000276	0.00105	CcSEcCtD
Loratadine—Headache—Doxorubicin—sarcoma	0.000274	0.00104	CcSEcCtD
Loratadine—Nausea—Doxorubicin—sarcoma	0.00026	0.000987	CcSEcCtD
